title: [Cutaneous leishmaniasis in a patient with ulcerative colitis under treatment with infliximab].
authors.affiliation: Servicio de Medicina Interna, Hospital Universitario de Puerto Real, Cádiz, España.
authors.forename: María Luisa
authors.initials: ML
authors.lastname: Fernández
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Puerto Real, Cádiz, España. Electronic address: ramirezfcol@hotmail.com.
authors.forename: Francisco
authors.initials: F
authors.lastname: Ramírez
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de Puerto Real, Cádiz, España.
authors.forename: Encarnación
authors.initials: E
authors.lastname: García
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069285:Infliximab / Q000009:adverse effects* / Q000627:therapeutic use; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000175:diagnosis
chemical_list: D000981:Antiprotozoal Agents; D007166:Immunosuppressive Agents; D010767:Phosphorylcholine; C039128:miltefosine; D000069285:Infliximab; D001379:Azathioprine